Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| REYNDERS MCVEIGH CAPITAL MANAGEMENT LLC | 08-13-2024 | 06-30-2024 | 198 | 1,760,390,000 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| AbbVie Inc. | COM | 51 | $6,220,000 | 36,267 | 0.35 | 0.40 | -4,630 | -11.32 | 06-30-2024 |
| CRISPR Therapeutics AG | NAMEN AKT | 52 | $6,193,000 | 114,673 | 0.35 | 0.36 | 22,625 | 24.58 | 06-30-2024 |
| Nike, Inc. | CL B | 53 | $5,846,000 | 77,560 | 0.33 | 2.34 | -263,050 | -77.23 | 06-30-2024 |
| Thermo Fisher Scientific Inc | COM | 54 | $5,775,000 | 10,443 | 0.33 | 0.35 | -6 | -0.06 | 06-30-2024 |
